About this trial
To develop and validate a structured scoring tool (robotic thyroidectomy assessment score, RTAS) for assessing and quantifying surgical performance in robotic thyroidectomy (RT).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm
Clinical diagnosis of benign thyroid nodules with a maximum diameter not exceeding 6 cm
Participants with high cosmetic expectations
Participants underwent robotic thyroidectomy without open conversion
Disqualifiers
Participants with history of neck surgery or radiation
Participants with vocal fold fixation by preoperative fibrolaryngoscope
Participants with preoperative examination suggestive of distant invasion
Participants with fusion or fixed of lymph nodes in the neck
Trial population
Patients were well informed about the robotic thyroidectomy and were aware of the potential benefits and risks. Patients underwent robotic thyroidectomy during the study period. Patient consented for us to use perioperative data.
Trial design
Cohort
Prospective
Treatments tested in this trial
Observations on clinicopathological factors influencing the assessment score of surgery
Other interventionAge, body mass index, gender, thyroid function parameters, lesion size, lesion location, ultrasound data
Treatment groups
Trial outcomes
Primary outcomes
Number of participants with recurrent laryngeal nerve injury
impaired vocal cord mobility confirmed by postoperative laryngoscopy
Number of participants with hypoparathyroidism
a postoperative parathyroid hormone level of less than 10 pg/ml
Operative time
operative time was defined as the duration from incision to closure, and was collected from anesthesia record sheet
Score for surgical competence
score evaluated by the proposed assessment system
Secondary outcomes
hospitalization
days of hospitalization
degree of pain
pain intensity was assessed using a standard visual analogue score, with a score of 0 to 10 corresponding to no pain to the most severe pain
Sponsors and contacts
Click on the lead sponsor to view all of their trials.